References
-
1) Low frequency pulsed electromagnetic fields exposure alleviate the abnormal subchondral bone remodeling at the early stage of temporomandibular joint osteoarthritis.
-
2) DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling.
-
3) Therapeutic effect of platelet-rich plasma on glucocorticoid-induced rat bone marrow mesenchymal stem cells in vitro.
-
4) Sensitizing TRAIL response via differential modulation of anti-and pro-apoptotic factors by AZD5582 combined with ER nanosomal TRAIL in neuroblastoma.
-
5) Enhancement of anti-inflammatory effect of cattle bile by fermentation and its inhibition of neuroinflammation on microglia by inhibiting NLRP3 inflammasome.
-
6) BPIFB2 is highly expressed in “cold” lung adenocarcinoma and decreases T cell chemotaxis via activation of the STAT3 pathway.
-
7) Identification of Biomarkers Related to Regulatory T Cell Infiltration in Oral Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
-
8) Dual VEGF/PDGF knockdown suppresses vasculogenic mimicry formation in choroidal melanoma cells via the Wnt5a/β-catenin/AKT signaling pathway.
-
9) Establishment of a New Cell Line of Canine Inflammatory Mammary Cancer: IMC‐118.
-
10) STAT4 regulates cardiomyocyte apoptosis in rat models of diabetic cardiomyopathy.
-
11) lncRNA MALAT1 mediates osteogenic differentiation of bone mesenchymal stem cells by sponging miR-129-5p.
-
12) Screening of immunosuppressive factors for biomarkers of breast cancer malignancy phenotypes and subtype-specific targeted therapy.
-
13) Neuropeptide S and its receptor NPSR enhance the susceptibility of hosts to pseudorabies virus infection.
-
14) Effect of e-cigarette refill liquid on follicular development and estrogen secretion in rats.
-
15) Betaine protects bovine mammary epithelial cells against LPS-induced inflammatory response and oxidative damage via modulating NF-κB and Nrf2 signalling pathway.
Product: 4Year: 2022Journal: ITAL J ANIM SCIImpactFactor: 2.200DOI: 10.1080/1828051X.2022.2070035